Carlinfante G, Lampugnani R, Azzoni C, Aprile M R, Brandi M L, Bordi C
Department of Anatomic Pathology, University of Parma, Italy.
J Pathol. 1998 Aug;185(4):389-93. doi: 10.1002/(SICI)1096-9896(199808)185:4<389::AID-PATH116>3.0.CO;2-T.
The alpha-subunit of human chorionic gonadotropin (hCG-alpha) has previously been found to be expressed in hyperplasias and tumours of numerous endocrine tissues including all those involved in MEN-I syndrome except the parathyroid glands. In the present immunohistochemical investigation of 86 patients with various states of hyperparathyroidism, expression of hCG-alpha by subsets of parathyroid cells was shown in 46 cases (54 per cent) including all states of hyperparathyroidism investigated: primary adenoma (n = 34, 44 per cent); uraemic secondary hyperplasia (n = 34, 53 per cent); MEN-I (n = 13, 77 per cent); MEN-II (n = 2, 100 per cent); and parathyroid carcinoma (n = 3, 100 per cent). Although the number of parathyroid cells expressing hCG-alpha was in general low, the occurrence of numerous immunoreactive cells appeared to be concentrated in primary adenoma and MEN-I (20 and 33 per cent of positive cases, respectively). No expression was found in ten normal control glands, except for very rare cells in one case. Expression of hCG-alpha was in part associated with that of hCG-beta, which appeared to be more commonly expressed than hCG-alpha in cases of secondary hyperparathyroidism. In separate experiments, Bouin fixation was found to preserve the immunoreactivity of hCG-alpha and hCG-beta better than the formalin fixation used in this study, suggesting that the figures may be underestimates. These immunohistochemical results are in agreement with a previous biochemical study showing hCG-alpha and hCG-beta in extracts of parathyroid tumours and extend to the parathyroid glands the otherwise ubiquitous finding of hCG-alpha expression in MEN-I-related neoplasms.
人绒毛膜促性腺激素α亚基(hCG-α)先前已被发现表达于众多内分泌组织的增生和肿瘤中,包括所有与多发性内分泌腺瘤病I型(MEN-I综合征)相关的组织,但甲状旁腺除外。在本次对86例不同甲状旁腺功能亢进状态患者的免疫组织化学研究中,46例(54%)甲状旁腺细胞亚群显示有hCG-α表达,涵盖了所研究的所有甲状旁腺功能亢进状态:原发性腺瘤(n = 34,44%);尿毒症继发性增生(n = 34,53%);MEN-I(n = 13,77%);MEN-II(n = 2,100%);以及甲状旁腺癌(n = 3,100%)。尽管表达hCG-α的甲状旁腺细胞数量总体较少,但大量免疫反应性细胞的出现似乎集中在原发性腺瘤和MEN-I(分别占阳性病例的20%和33%)。在10个正常对照腺体中未发现表达,仅1例有极罕见细胞表达。hCG-α的表达部分与hCG-β相关,在继发性甲状旁腺功能亢进病例中,hCG-β的表达似乎比hCG-α更常见。在单独实验中,发现Bouin固定比本研究中使用的福尔马林固定能更好地保留hCG-α和hCG-β的免疫反应性,提示这些数据可能被低估。这些免疫组织化学结果与先前一项生化研究一致,该研究显示甲状旁腺肿瘤提取物中有hCG-α和hCG-β,并将MEN-I相关肿瘤中普遍存在的hCG-α表达扩展到了甲状旁腺。